{
  "manuscript_id": "EMBOJ-2023-115257",
  "xml": "EMBOJ-2023-115257.xml",
  "docx": "Doc/EMBOJ2023115257R1Manuscript_TextIG.docx",
  "pdf": "pdf/EMBOJ-2023-115257.pdf",
  "appendix": ["suppl_data/Appendix.pdf"],
  "sd_files": [
    "suppl_data/EMBOJ2023115257RFigure_3sd.zip",
    "suppl_data/EMBOJ2023115257RFigure_4sd.zip",
    "suppl_data/EMBOJ2023115257RFigure_5sd.zip",
    "suppl_data/EMBOJ2023115257RFigure_6sd.zip"
  ],
  "figures": [
    {
      "figure_label": "Figure 1",
      "img_files": ["graphic/FIGURE 1.tif"],
      "sd_files": [],
      "figure_caption": "\n\n<p><strong>A)</strong> Heatmap representation of RNAseq differentially\nexpressed TEs (LogFC&gt;0.5) between 4h post-injury and intact femurs at\ndifferent time points of the bone healing process. N=5 biological\nreplicates for each time point. N=10 biological replicates for intact\nfemur. <strong>B)</strong> Heatmap representation of RNAseq upregulated\nTEs (LogFC&gt;0.5) between 4h and intact at different time points of the\nbone healing process. N=5 biological replicates for each time point.\nN=10 biological replicates for intact femur. <strong>C)</strong> Heatmap\nrepresentation of RNAseq differentially expressed TEs analysis\n[Fragments Per Kilobase of transcript per Million (FPKM) fold change] in\nfemoral (n=27) and iliac (n=34) bone biopsies from healthy donors.\n<strong>D)</strong> Pie charts showing the number and percentage of\ndifferentially expressed TEs subfamilies between femoral and iliac\nhealthy bone. <strong>E)</strong> Heatmap representation of RNAseq\ndifferentially expressed TEs analysis [Fragments Per Kilobase of\ntranscript per Million (FPKM) fold change] in femoral (n=27) and iliac\n(n=34) bone biopsies from healthy donors. One heatmap for each TEs order\nis shown.</p>\n\n",
      "caption_title": "TEs expression is induced after fracture and inmechanically loaded bone.",
      "panels": [
        {
          "panel_label": "A",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "B",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "C",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "D",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "E",
          "panel_caption": "",
          "sd_files": []
        }
      ]
    },
    {
      "figure_label": "Figure 2",
      "img_files": ["graphic/FIGURE 2.tif"],
      "sd_files": [],
      "figure_caption": "\n\n<p><strong>A)</strong> Heatmap representation of RNAseq differentially\nexpressed TEs analysis [Fragments Per Kilobase of transcript per Million\n(FPKM) fold change] in femoral bone from healthy (n=27), osteopenic\n(n=12), and osteoporotic (n=9) donors. <strong>B)</strong> Heatmap\nrepresentation of RNAseq differentially expressed TEs analysis\n[Fragments Per Kilobase of transcript per Million (FPKM) fold change] in\nfemoral bone with high BMD (FN T-score &gt;-1) (n=27) and low BMD (FN\nT-score &lt;-1) (n=21). <strong>C)</strong> Upper panels: pie charts\nshowing the number and percentage of differentially expressed TEs\nsubfamilies between high BMD and low BMD femoral bone. Lower panels:\nheatmap representation of RNAseq differentially expressed TEs analysis\n[Fragments Per Kilobase of transcript per Million (FPKM) fold change] in\nfemoral bone with high BMD (n=27) and low BMD (n=21). One heatmap for\neach TEs order is shown. <strong>D)</strong> Upper panels: Heatmap\nrepresentation of correlation analysis (<em>P</em> value&lt;0.05)\nbetween TEs expression (FPKM) and local BMD (FN T-score) in femoral bone\nbiopsies (n=48). Correlation between TE expression (FPKM values) and FN\nt-score was evaluated using Pearson method. Significant correlations\n(p-value &lt; 0.05) were selected for the heatmap representation and\narranged according to the Pearson correlation coefficient (r). r &gt; 0,\npositive correlations; r &lt; 0, negative correlations. Lower panels:\nPie charts showing the percentage of TEs subfamilies positively\ncorrelated to local BMD.</p>\n\n",
      "caption_title": "TEs expression correlates with bone mineral density in human weight-bearing bone.",
      "panels": [
        {
          "panel_label": "A",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "B",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "C",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "D",
          "panel_caption": "",
          "sd_files": []
        }
      ]
    },
    {
      "figure_label": "Figure 3",
      "img_files": ["graphic/FIGURE 3.tif"],
      "sd_files": ["suppl_data/EMBOJ2023115257RFigure_3sd.zip"],
      "figure_caption": "\n\n<p><strong>A)</strong> Experimental workflow and flow cytometer analysis\nshowing the percentage of positive cells 6 hours after L1 RNA delivery\nat day 5 of <em>ex vivo</em> osteogenesis. Intracellular localization of\ncy5 conjugated synthetic L1 RNA (red spots) three days after\ntransfection is also shown from a typical experiment (right).\n<strong>B)</strong> qPCR analysis of intracellular L1 RNA level 24 h\n(d6), 5 days (d10), and 9 days (d14) post-transfection. The graph is\nshown as mean\u2009±\u2009s.d. of n\u2009=3 independent experiments.\n<strong>C)</strong> cy5 conjugated synthetic L1 RNA (red) and osteoimage\nstained mineral matrix (green) detection 9 days post L1 RNA\ntransfection. The white arrowheads indicate the colocalization between\nL1 RNA and hydroxyapatite. <strong>D)</strong> Osteoimage stained\nmineral matrix quantification (upper panels), images (central panels),\nand Alizarin Red (lower panels) 9 days after L1 RNA or RFP RNA delivery\nin 2 healthy donors-derived MSCs (D188 and D170). RFU= Relative\nFluorescence Units. The graph is shown as mean\u2009±\u2009s.d. of n\u2009=\u200911\ntechnical replicates. ****P\u2009&lt;\u20090.00005 in Wilcoxon test.\n<strong>E)</strong> Alizarin Red staining of osteoblasts transfected\nwith increasing doses of RFP RNA (upper panels) and L1 RNA (lower\npanels). <strong>F)</strong> Alizarin Red images (upper panel) and\nquantification (lower panel) of MSCs mineralization after 14, 17 and 21\ndays of <em>ex vivo</em> differentiation. MSCs were obtained from the\nfemur of 4 healthy (D188, D239, D247, D170) and 4 OP patients (HUK7,\nHUK9, HUK12, HUK16). N=9 technical replicates for each donor and time\npoint. Boxes in the boxplot indicate the interquartile range (50% of\ndata), while the lower end and the upper end represent the\n1<sup>st</sup> and the 3<sup>rd</sup> quartile, respectively. The solid\nline inside the box represents the median. Whiskers represent the max\nand min values. Values that are not within 1.5 times the interquartile\nrange are considered as outliers and lie outside the whiskers.\n<strong>G)</strong> Osteoimage stained mineral matrix quantification\n(upper panels), images (central panels), and Alizarin Red (lower panels)\n9 days after L1 RNA or RFP RNA delivery in 3 OP patients derived MSCs\n(HUK9, HUK12, HUK16). RFU= Relative Fluorescence Units. The graph is\nshown as mean\u2009±\u2009s.d. of n\u2009=\u200910-12 technical replicates.\n****P\u2009&lt;\u20090.00005 in Wilcoxon test. <strong>H)</strong> qRT-PCR of\nearly osteogenic genes in RFP and L1 transfected osteoblasts at\ndifferent time points of osteogenic differentiation. Expression level is\nnormalized on day 5 (not transfected osteoblasts). N=3 biological\nreplicates. The graph is shown as mean\u2009±\u2009s.d. of n\u2009=\u20093 independent\nexperiments. *P\u2009&lt;\u20090.05; **P\u2009&lt;\u20090.005, ***P\u2009&lt;\u20090.0005,\n****P\u2009&lt;\u20090.00005 in Student’s t test.</p>\n\n",
      "caption_title": "L1 RNA delivery stimulates the mineralization of differentiating osteoblasts",
      "panels": [
        {
          "panel_label": "A",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "B",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3B/3B RT-qPCR rel expression.xlsx"
          ]
        },
        {
          "panel_label": "C",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3C/3C micr image.TIF"
          ]
        },
        {
          "panel_label": "D",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D quantification.xlsx",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D osteoimages/D170 osteo RFP.TIF",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D osteoimages/D188 dapi L1.TIF",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D osteoimages/D170 dapi L1.TIF",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D osteoimages/D170 osteo L1.TIF",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D osteoimages/D188 osteo L1.TIF",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D osteoimages/D188 osteo RFP.TIF",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D osteoimages/D170 dapi RFP.TIF",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D osteoimages/D188 dapi RFP.TIF",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D  Alizarin images/D170 RFP.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D  Alizarin images/3D README.docx",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D  Alizarin images/D188 L1.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D  Alizarin images/D170 L1.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3D/3D  Alizarin images/D188 RFP.jpg"
          ]
        },
        {
          "panel_label": "E",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/RFP 10,6 .jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/L1 70.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/RFP 116.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/RFP 70.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/RFP770.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/3E README.docx",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/L1 32.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/L1 3,5.jpg",
            "uppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/RFP 3,5.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/RFP 32.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/RFP 350.jpg",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3E/L1 10,6.jpg"
          ]
        },
        {
          "panel_label": "F",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F quantification.xlsx",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK7_d21.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D188_d21.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK12_d14.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D247_d21.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK16_d21.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK12_d17.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D170_d14.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK9_d17.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D239_d14.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D170_d17.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK9_d14.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D239_d17.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK12_d21.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D188_d14.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D247_d14.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK16_d14.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D188_d17.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D247_d17.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK16_d17.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D170_d21.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/D239_d21.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK9_d21.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK7_d17.png",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3F/3F micr image/HUK7_d14.png"
          ]
        },
        {
          "panel_label": "G",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G quantification.xlsx",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk16 dapi L1.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk12 osteo L1.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk9 osteo L1.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk9 dapi L1.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk16 dapi RFP.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk12 osteo RFP.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk16 osteo RFP.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk12 dapi L1.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk9 dapi RFP.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk12 dapi RFP.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk9 osteo RFP.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G osteoimages/huk16 osteo L1.tif",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G Alizarin images/HUK9 RFP.JPG",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G Alizarin images/HUK9 L1.JPG",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G Alizarin images/HUK12 RFP.JPG",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G Alizarin images/3G README.docx",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G Alizarin images/HUK12 L1.JPG",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G Alizarin images/HUK16 L1.JPG",
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3G/3G Alizarin images/HUK16 RFP.JPG"
          ]
        },
        {
          "panel_label": "H",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_3sd.zip:Figure 3/3H/3H quantification.xlsx"
          ]
        }
      ]
    },
    {
      "figure_label": "Figure 4",
      "img_files": ["graphic/FIGURE 4.tif"],
      "sd_files": ["suppl_data/EMBOJ2023115257RFigure_4sd.zip"],
      "figure_caption": "\n\n<p><strong>A)</strong> Left panel: heatmap representation of RNAseq\ndifferentially expressed gene analysis [Fragments Per Kilobase of\ntranscript per Million (FPKM) fold change] in osteoblasts transfected\nwith negative control RNA (RFP) or L1 RNA. Right panel: bubble plot\nshowing gene ontology (GO) enrichment analysis of L1 upregulated\nbiological processes. <strong>B)</strong> Tree plot showing gene\nontology (GO) enrichment analysis of L1 upregulated biological processes\n(left) and cellular components (right). <strong>C)</strong> Top 25\nupregulated biological processes 24h post-L1 RNA delivery <em>in\nvitro</em> (yellow) and 4h post fracture <em>in vivo</em> (blue). Shared\nGO terms are shown in green. <strong>D)</strong> qPCR analysis of\n“inflammatory response” (GO:0006954) and “immune response” (GO:0006955)\ngenes at different time points post L1 RNA transfection at day 5. *\n**P\u2009&lt;\u20090.005, ****P\u2009&lt;\u20090.00005 in two way ANOVA.</p>\n\n",
      "caption_title": "L1 RNA delivery induces an inflammatory response characteristic of bone repair process",
      "panels": [
        {
          "panel_label": "A",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "B",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "C",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "D",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_4sd.zip:Figure 4/4D/4D RT-qPCR rel expression.xlsx"
          ]
        }
      ]
    },
    {
      "figure_label": "Figure 5",
      "img_files": ["graphic/FIGURE 5.tif"],
      "sd_files": ["suppl_data/EMBOJ2023115257RFigure_5sd.zip"],
      "figure_caption": "\n\n<p><strong>A)</strong> Upper panel: schematic representation of the\npathway inhibited by Lamivudine 3TC and G140. Lower panel: Alizarin Red\nstaining of differentiating osteoblasts transfected with L1 RNA and\ntreated with Lamivudine 3TC and G140. <strong>B)</strong> IF on RFP and\nL1 transfected osteoblasts, 6h post-transfection, shows the\ncolocalization between cy5 signal (L1 RNA, red) and 488-Anti-dsRNA\nsignal (dsRNA, green). Nuclei are stained with Hoechst (blue).</p>\n<p><strong>C)</strong>Western blot analysis showing the ratio between\ntotal eIF2α and phosphorylated eIF2α (P- eIF2α). H3: endogenous standard\nHistone 3. <strong>D)</strong> Volcano plot (left) showing the number of\nsignificantly upregulated and downregulated protein 24h post-L1 RNA\ntransfection. Right: tree plots showing gene ontology (GO) enrichment\nanalysis of biological processes (upper panel) and cellular components\n(lower panel) downregulated by L1 RNA delivery (MS data).\n<strong>E)</strong> qPCR analysis of “inflammatory response”\n(GO:0006954) and “immune response” (GO:0006955) genes 24h post L1 RNA\ntransfection with and without PKR inhibitor C16. <strong>F)</strong>\nAlizarin Red staining of differentiating osteoblasts transfected with L1\nRNA with and without PKR inhibitor C16. <strong>G)</strong> Tree plots\nshowing gene ontology (GO) enrichment analysis of biological processes\nupregulated by L1 RNA 24h after transfection (MS data).</p>\n\n",
      "caption_title": "PKR mediates L1 RNA-induced stress response and mineralization",
      "panels": [
        {
          "panel_label": "A",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5A/5A images/L1.jpg",
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5A/5A images/L1 3TC.jpg",
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5A/5A images/3TC.jpg",
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5A/5A images/G140.jpg",
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5A/5A images/L1 G140.jpg"
          ]
        },
        {
          "panel_label": "B",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "C",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5C/5C README.pdf",
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5C/H3.tif",
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5C/eIF2alpha.tif",
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5C/merge.tif",
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5C/P-eIF2alpha.tif"
          ]
        },
        {
          "panel_label": "D",
          "panel_caption": "",
          "sd_files": []
        },
        {
          "panel_label": "E",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5E/5E RT-qPCR rel expression.xlsx"
          ]
        },
        {
          "panel_label": "F",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_5sd.zip:Figure 5/5F/5F image.jpg"
          ]
        },
        {
          "panel_label": "G",
          "panel_caption": "",
          "sd_files": []
        }
      ]
    },
    {
      "figure_label": "Figure 6",
      "img_files": ["graphic/FIGURE 6.tif"],
      "sd_files": ["suppl_data/EMBOJ2023115257RFigure_6sd.zip"],
      "figure_caption": "\n\n<p><strong>A)</strong> Upper panel: schematic representation of the\npathway inhibited by Lamivudine 3TC and G140. Lower panel: Alizarin Red\nstaining of differentiating osteoblasts transfected with L1 RNA and\ntreated with Lamivudine 3TC and G140. <strong>B)</strong> IF on RFP and\nL1 transfected osteoblasts, 6h post-transfection, shows the\ncolocalization between cy5 signal (L1 RNA, red) and 488-Anti-dsRNA\nsignal (dsRNA, green). Nuclei are stained with Hoechst (blue).</p>\n<p><strong>C)</strong>Western blot analysis showing the ratio between\ntotal eIF2α and phosphorylated eIF2α (P- eIF2α). H3: endogenous standard\nHistone 3. <strong>D)</strong> Volcano plot (left) showing the number of\nsignificantly upregulated and downregulated protein 24h post-L1 RNA\ntransfection. Right: tree plots showing gene ontology (GO) enrichment\nanalysis of biological processes (upper panel) and cellular components\n(lower panel) downregulated by L1 RNA delivery (MS data).\n<strong>E)</strong> qPCR analysis of “inflammatory response”\n(GO:0006954) and “immune response” (GO:0006955) genes 24h post L1 RNA\ntransfection with and without PKR inhibitor C16. <strong>F)</strong>\nAlizarin Red staining of differentiating osteoblasts transfected with L1\nRNA with and without PKR inhibitor C16. <strong>G)</strong> Tree plots\nshowing gene ontology (GO) enrichment analysis of biological processes\nupregulated by L1 RNA 24h after transfection (MS data).</p>\n\n",
      "caption_title": "L1-RNA-induced changes in osteoblast secretome ",
      "panels": [
        {
          "panel_label": "A",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/6A image.jpg",
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/RFP.JPG",
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/L1.JPG",
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/NT.JPG"
          ]
        },
        {
          "panel_label": "B",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/RFP.JPG",
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/L1.JPG",
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/NT.JPG"
          ]
        },
        {
          "panel_label": "C",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/RFP.JPG",
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/L1.JPG",
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/NT.JPG"
          ]
        },
        {
          "panel_label": "D",
          "panel_caption": "",
          "sd_files": [
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/RFP.JPG",
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/L1.JPG",
            "suppl_data/EMBOJ2023115257RFigure_6sd.zip:Figure 6/NT.JPG"
          ]
        }
      ]
    }
  ],
  "data_availability": {
    "section_text": "\n\n<p>The RNA-seq transcriptomics data on human bone biopsies have been\ndeposited to BioProject with the dataset identifier PRJNA764663\n(https://www.ncbi.nlm.nih.gov/bioproject/PRJNA764663). The RNA-seq\ntranscriptomics data on transfected osteoblasts have been deposited to\nGEO with the dataset identifier GSE201774\n(https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE201774) (enter\ntoken: ififogaehzoxlgh).</p>\n<p>The mass spectrometry proteomics data have been deposited to the\nProteomeXchange Consortium via the PRIDE partner repository with the\ndataset identifier PXD051195. Reviewer account details are username: <a\nhref=\"mailto:reviewer_pxd051195@ebi.ac.uk\">reviewer_pxd051195@ebi.ac.uk</a>\n; password: R6v0mIYe</p>\n\n'",
    "data_sources": [
      {
        "database": "BioProject",
        "accession_number": "PRJNA764663",
        "url": "https://www.ncbi.nlm.nih.gov/bioproject/PRJNA764663"
      },
      {
        "database": "GEO Data Sets",
        "accession_number": "GSE201774",
        "url": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE201774"
      },
      {
        "database": "ProteomeXchange  Consortium, PRIDE",
        "accession_number": "PXD051195",
        "url": "https://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD051195"
      }
    ]
  },
  "all_captions": "\n\n<p><strong>Figure Legends</strong></p>\n<p><strong>Figure 1 - TEs expression is induced after fracture and in\nmechanically loaded bone.</strong></p>\n<p><strong>A)</strong> Heatmap representation of RNAseq differentially\nexpressed TEs (LogFC&gt;0.5) between 4h post-injury and intact femurs at\ndifferent time points of the bone healing process. N=5 biological\nreplicates for each time point. N=10 biological replicates for intact\nfemur. <strong>B)</strong> Heatmap representation of RNAseq upregulated\nTEs (LogFC&gt;0.5) between 4h and intact at different time points of the\nbone healing process. N=5 biological replicates for each time point.\nN=10 biological replicates for intact femur. <strong>C)</strong> Heatmap\nrepresentation of RNAseq differentially expressed TEs analysis\n[Fragments Per Kilobase of transcript per Million (FPKM) fold change] in\nfemoral (n=27) and iliac (n=34) bone biopsies from healthy donors.\n<strong>D)</strong> Pie charts showing the number and percentage of\ndifferentially expressed TEs subfamilies between femoral and iliac\nhealthy bone. <strong>E)</strong> Heatmap representation of RNAseq\ndifferentially expressed TEs analysis [Fragments Per Kilobase of\ntranscript per Million (FPKM) fold change] in femoral (n=27) and iliac\n(n=34) bone biopsies from healthy donors. One heatmap for each TEs order\nis shown.</p>\n<p><strong>Figure 2 - TEs expression correlates with bone mineral\ndensity in human weight-bearing bone.</strong></p>\n<p><strong>A)</strong> Heatmap representation of RNAseq differentially\nexpressed TEs analysis [Fragments Per Kilobase of transcript per Million\n(FPKM) fold change] in femoral bone from healthy (n=27), osteopenic\n(n=12), and osteoporotic (n=9) donors. <strong>B)</strong> Heatmap\nrepresentation of RNAseq differentially expressed TEs analysis\n[Fragments Per Kilobase of transcript per Million (FPKM) fold change] in\nfemoral bone with high BMD (FN T-score &gt;-1) (n=27) and low BMD (FN\nT-score &lt;-1) (n=21). <strong>C)</strong> Upper panels: pie charts\nshowing the number and percentage of differentially expressed TEs\nsubfamilies between high BMD and low BMD femoral bone. Lower panels:\nheatmap representation of RNAseq differentially expressed TEs analysis\n[Fragments Per Kilobase of transcript per Million (FPKM) fold change] in\nfemoral bone with high BMD (n=27) and low BMD (n=21). One heatmap for\neach TEs order is shown. <strong>D)</strong> Upper panels: Heatmap\nrepresentation of correlation analysis (<em>P</em> value&lt;0.05)\nbetween TEs expression (FPKM) and local BMD (FN T-score) in femoral bone\nbiopsies (n=48). Correlation between TE expression (FPKM values) and FN\nt-score was evaluated using Pearson method. Significant correlations\n(p-value &lt; 0.05) were selected for the heatmap representation and\narranged according to the Pearson correlation coefficient (r). r &gt; 0,\npositive correlations; r &lt; 0, negative correlations. Lower panels:\nPie charts showing the percentage of TEs subfamilies positively\ncorrelated to local BMD.</p>\n<p><strong>Figure 3 - L1 RNA delivery stimulates the mineralization of\ndifferentiating osteoblasts</strong></p>\n<p><strong>A)</strong> Experimental workflow and flow cytometer analysis\nshowing the percentage of positive cells 6 hours after L1 RNA delivery\nat day 5 of <em>ex vivo</em> osteogenesis. Intracellular localization of\ncy5 conjugated synthetic L1 RNA (red spots) three days after\ntransfection is also shown from a typical experiment (right).\n<strong>B)</strong> qPCR analysis of intracellular L1 RNA level 24 h\n(d6), 5 days (d10), and 9 days (d14) post-transfection. The graph is\nshown as mean\u2009±\u2009s.d. of n\u2009=3 independent experiments.\n<strong>C)</strong> cy5 conjugated synthetic L1 RNA (red) and osteoimage\nstained mineral matrix (green) detection 9 days post L1 RNA\ntransfection. The white arrowheads indicate the colocalization between\nL1 RNA and hydroxyapatite. <strong>D)</strong> Osteoimage stained\nmineral matrix quantification (upper panels), images (central panels),\nand Alizarin Red (lower panels) 9 days after L1 RNA or RFP RNA delivery\nin 2 healthy donors-derived MSCs (D188 and D170). RFU= Relative\nFluorescence Units. The graph is shown as mean\u2009±\u2009s.d. of n\u2009=\u200911\ntechnical replicates. ****P\u2009&lt;\u20090.00005 in Wilcoxon test.\n<strong>E)</strong> Alizarin Red staining of osteoblasts transfected\nwith increasing doses of RFP RNA (upper panels) and L1 RNA (lower\npanels). <strong>F)</strong> Alizarin Red images (upper panel) and\nquantification (lower panel) of MSCs mineralization after 14, 17 and 21\ndays of <em>ex vivo</em> differentiation. MSCs were obtained from the\nfemur of 4 healthy (D188, D239, D247, D170) and 4 OP patients (HUK7,\nHUK9, HUK12, HUK16). N=9 technical replicates for each donor and time\npoint. Boxes in the boxplot indicate the interquartile range (50% of\ndata), while the lower end and the upper end represent the\n1<sup>st</sup> and the 3<sup>rd</sup> quartile, respectively. The solid\nline inside the box represents the median. Whiskers represent the max\nand min values. Values that are not within 1.5 times the interquartile\nrange are considered as outliers and lie outside the whiskers.\n<strong>G)</strong> Osteoimage stained mineral matrix quantification\n(upper panels), images (central panels), and Alizarin Red (lower panels)\n9 days after L1 RNA or RFP RNA delivery in 3 OP patients derived MSCs\n(HUK9, HUK12, HUK16). RFU= Relative Fluorescence Units. The graph is\nshown as mean\u2009±\u2009s.d. of n\u2009=\u200910-12 technical replicates.\n****P\u2009&lt;\u20090.00005 in Wilcoxon test. <strong>H)</strong> qRT-PCR of\nearly osteogenic genes in RFP and L1 transfected osteoblasts at\ndifferent time points of osteogenic differentiation. Expression level is\nnormalized on day 5 (not transfected osteoblasts). N=3 biological\nreplicates. The graph is shown as mean\u2009±\u2009s.d. of n\u2009=\u20093 independent\nexperiments. *P\u2009&lt;\u20090.05; **P\u2009&lt;\u20090.005, ***P\u2009&lt;\u20090.0005,\n****P\u2009&lt;\u20090.00005 in Student’s t test.</p>\n<p><strong>Figure 4 - L1 RNA delivery induces an inflammatory response\ncharacteristic of bone repair process</strong></p>\n<p><strong>A)</strong> Left panel: heatmap representation of RNAseq\ndifferentially expressed gene analysis [Fragments Per Kilobase of\ntranscript per Million (FPKM) fold change] in osteoblasts transfected\nwith negative control RNA (RFP) or L1 RNA. Right panel: bubble plot\nshowing gene ontology (GO) enrichment analysis of L1 upregulated\nbiological processes. <strong>B)</strong> Tree plot showing gene\nontology (GO) enrichment analysis of L1 upregulated biological processes\n(left) and cellular components (right). <strong>C)</strong> Top 25\nupregulated biological processes 24h post-L1 RNA delivery <em>in\nvitro</em> (yellow) and 4h post fracture <em>in vivo</em> (blue). Shared\nGO terms are shown in green. <strong>D)</strong> qPCR analysis of\n“inflammatory response” (GO:0006954) and “immune response” (GO:0006955)\ngenes at different time points post L1 RNA transfection at day 5. *\n**P\u2009&lt;\u20090.005, ****P\u2009&lt;\u20090.00005 in two way ANOVA.</p>\n<p><strong>Figure 5 - PKR mediates L1 RNA-induced stress response and\nmineralization</strong></p>\n<p><strong>A)</strong> Upper panel: schematic representation of the\npathway inhibited by Lamivudine 3TC and G140. Lower panel: Alizarin Red\nstaining of differentiating osteoblasts transfected with L1 RNA and\ntreated with Lamivudine 3TC and G140. <strong>B)</strong> IF on RFP and\nL1 transfected osteoblasts, 6h post-transfection, shows the\ncolocalization between cy5 signal (L1 RNA, red) and 488-Anti-dsRNA\nsignal (dsRNA, green). Nuclei are stained with Hoechst (blue).</p>\n<p><strong>C)</strong>Western blot analysis showing the ratio between\ntotal eIF2α and phosphorylated eIF2α (P- eIF2α). H3: endogenous standard\nHistone 3. <strong>D)</strong> Volcano plot (left) showing the number of\nsignificantly upregulated and downregulated protein 24h post-L1 RNA\ntransfection. Right: tree plots showing gene ontology (GO) enrichment\nanalysis of biological processes (upper panel) and cellular components\n(lower panel) downregulated by L1 RNA delivery (MS data).\n<strong>E)</strong> qPCR analysis of “inflammatory response”\n(GO:0006954) and “immune response” (GO:0006955) genes 24h post L1 RNA\ntransfection with and without PKR inhibitor C16. <strong>F)</strong>\nAlizarin Red staining of differentiating osteoblasts transfected with L1\nRNA with and without PKR inhibitor C16. <strong>G)</strong> Tree plots\nshowing gene ontology (GO) enrichment analysis of biological processes\nupregulated by L1 RNA 24h after transfection (MS data).</p>\n<p><strong>Figure 6 - L1-RNA-induced changes in osteoblast\nsecretome</strong></p>\n<p><strong>A)</strong> Left: Alizarin red staining on recipient OB 9\ndays after the delivery of conditioned media. Right: Microscope images\nof recipient OB 24h from the delivery of conditioned media. Mineralized\nnodules in OB receiving conditioned media from L1 treated OB are shown\n(orange arrows). <strong>B)</strong> Heat map of differentially\nexpressed proteins in bulk secretome and exosomes derived from\nuntransfected (NT), RFP- and L1-transfected osteoblasts. N=3 biological\nreplicates. <strong>C)</strong> GO enrichment analysis of differentially\nexpressed protein (adjusted p-value &lt;0.05) in the bulk secretome of\nL1 compared to RFP transfected osteoblasts. <strong>D)</strong> GO\nenrichment analysis of differentially expressed protein (adjusted\np-value &lt;0.05) in the exosomes of L1 compared to RFP transfected\nosteoblasts.</p>\n\n"
}
